0001193125-21-114679.txt : 20210413 0001193125-21-114679.hdr.sgml : 20210413 20210413160704 ACCESSION NUMBER: 0001193125-21-114679 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210413 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210413 DATE AS OF CHANGE: 20210413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zymeworks Inc. CENTRAL INDEX KEY: 0001403752 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38068 FILM NUMBER: 21823157 BUSINESS ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 BUSINESS PHONE: (604) 678-1388 MAIL ADDRESS: STREET 1: 540-1385 WEST 8TH AVENUE CITY: Vancouver STATE: A1 ZIP: V6H 3V9 FORMER COMPANY: FORMER CONFORMED NAME: Zymeworks Inc DATE OF NAME CHANGE: 20070620 8-K 1 d149094d8k.htm 8-K 8-K
0001403752 false 0001403752 2021-04-13 2021-04-13

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 13, 2021

 

 

Zymeworks Inc.

(Exact name of registrant as specified in its charter)

 

 

 

British Columbia, Canada   001-38068   98-1398788

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

Suite 540, 1385 West 8th Avenue, Vancouver, British Columbia,

Canada

  V6H 3V9
(Address of principal executive offices)   (Zip Code)

(604) 678-1388

(Registrant’s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange

on which registered

Common Shares, no par value per share   ZYME   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


ITEM 7.01

REGULATION FD DISCLOSURE

On April 13, 2021, Zymeworks Inc. (“Zymeworks”) issued a press release announcing that Zymeworks will present at the upcoming 2021 Bloom Burton Healthcare Investor Conference taking place April 20-21, 2021.

On April 13, 2021, Zymeworks filed this press release with the Canadian securities regulatory authorities in Canada on the System for Electronic Document Analysis and Retrieval (“SEDAR”) at www.sedar.com. A copy of this press release is attached as Exhibit 99.1 hereto.

The information provided under this Item (including Exhibit 99.1, attached hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

ITEM 9.01

FINANCIAL STATEMENTS AND EXHIBITS

 

      (d)

Exhibits

 

Exhibit
    No.    

  

Description

99.1    Press Release dated April 13, 2021.
104    Cover Page Interactive Data File (embedded as Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

ZYMEWORKS INC.

    (Registrant)
Date: April 13, 2021     By:  

/s/ Neil A. Klompas

    Name:   Neil A. Klompas
    Title:  

Executive Vice President, Business

Operations and Chief Financial Officer

EX-99.1 2 d149094dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

Zymeworks to Present at Bloom Burton Healthcare Conference

Vancouver, British Columbia (April 13, 2021) – Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that the Company will present at the upcoming 2021 Bloom Burton Healthcare Investor Conference taking place April 20-21, 2021.

The Company’s presentation will be on Tuesday, April 20, 2021 at 11:30 a.m. ET.

Interested parties can access a live webcast of the presentation via a link from Zymeworks’ website at http://ir.zymeworks.com/events-and-presentations, which will also host a recorded replay available afterwards.

About Zymeworks Inc.

Zymeworks is a clinical-stage biopharmaceutical company dedicated to the development of next-generation multifunctional biotherapeutics. Zymeworks’ suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of highly differentiated product candidates. Zymeworks’ lead clinical candidate, zanidatamab (ZW25), is a novel Azymetric bispecific antibody which has been granted Breakthrough Therapy designation by the FDA and is currently enrolling in a pivotal clinical trial for refractory HER2-amplified biliary tract cancer (HERIZON-BTC-01) as well as several Phase 2 clinical trials for HER2-expressing gastroesophageal and breast cancers. Zymeworks’ second clinical candidate, ZW49, is a novel bispecific HER2-targeting antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody framework of zanidatamab with Zymeworks’ proprietary ZymeLink linker and cytotoxin. Zymeworks is also advancing a deep preclinical pipeline in oncology (including immuno-oncology agents) and other therapeutic areas. In addition, its therapeutic platforms are being leveraged through strategic partnerships with nine biopharmaceutical companies. For additional information about Zymeworks, visit www.zymeworks.com and follow @ZymeworksInc on Twitter.

Contacts:

Investor Inquiries:

Ryan Dercho, Ph.D.

(604) 678-1388

ir@zymeworks.com

Tiffany Tolmie

(604) 678-1388

ir@zymeworks.com

Media Inquiries:

Mary Klem

(604) 678-1388

media@zymeworks.com

EX-101.SCH 3 zyme-20210413.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 zyme-20210413_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Country Entity Address, Country Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag EX-101.PRE 5 zyme-20210413_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g149094g0413140544753.jpg GRAPHIC begin 644 g149094g0413140544753.jpg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d149094d8k_htm.xml IDEA: XBRL DOCUMENT 0001403752 2021-04-13 2021-04-13 0001403752 false 8-K 2021-04-13 Zymeworks Inc. A1 001-38068 98-1398788 Suite 540, 1385 West 8th Avenue Vancouver BC CA V6H 3V9 604 678-1388 false false false false Common Shares, no par value per share ZYME NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document and Entity Information
Apr. 13, 2021
Cover [Abstract]  
Document Type 8-K
Document Period End Date Apr. 13, 2021
Entity Registrant Name Zymeworks Inc.
Entity Incorporation, State or Country Code A1
Entity File Number 001-38068
Entity Tax Identification Number 98-1398788
Entity Address, Address Line One Suite 540, 1385 West 8th Avenue
Entity Address, City or Town Vancouver
Entity Address, State or Province BC
Entity Address, Country CA
Entity Address, Postal Zip Code V6H 3V9
City Area Code 604
Local Phone Number 678-1388
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, no par value per share
Trading Symbol ZYME
Security Exchange Name NYSE
Entity Emerging Growth Company false
Entity Central Index Key 0001403752
Amendment Flag false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d149094d8k.htm d149094dex991.htm zyme-20210413.xsd zyme-20210413_lab.xml zyme-20210413_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d149094d8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "d149094d8k.htm" ] }, "labelLink": { "local": [ "zyme-20210413_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "zyme-20210413_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "zyme-20210413.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "zyme", "nsuri": "http://www.zymeworks.com/20210413", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d149094d8k.htm", "contextRef": "duration_2021-04-13_to_2021-04-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d149094d8k.htm", "contextRef": "duration_2021-04-13_to_2021-04-13", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country", "terseLabel": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.zymeworks.com//20210413/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001193125-21-114679-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-114679-xbrl.zip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end